These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Bate CA; Taverne J; Playfair JH Immunology; 1989 Apr; 66(4):600-5. PubMed ID: 2654012 [TBL] [Abstract][Full Text] [Related]
7. Malaria, blood glucose, and the role of tumour necrosis factor (TNF) in mice. Elased KM; Taverne J; Playfair JH Clin Exp Immunol; 1996 Sep; 105(3):443-9. PubMed ID: 8809132 [TBL] [Abstract][Full Text] [Related]
8. Induction of TNF in vitro as a model for the identification of toxic malaria antigens. Taverne J; Bate CA; Playfair JH Lymphokine Res; 1989; 8(3):317-22. PubMed ID: 2674557 [TBL] [Abstract][Full Text] [Related]
9. Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody. Taverne J; Bate CA; Playfair JH Immunol Lett; 1990 Aug; 25(1-3):207-12. PubMed ID: 2283151 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of antigen specific and non-specific polyclonal B-cell responses during lethal Plasmodium yoelii malaria. Rolland L; Ballet JJ; Daniel-Ribeiro C Mem Inst Oswaldo Cruz; 1992; 87(2):197-204. PubMed ID: 1284989 [TBL] [Abstract][Full Text] [Related]
11. Don't kill the parasite: control the disease. Playfair JH; Taverne J; Bate CA Acta Leiden; 1991; 60(1):157-65. PubMed ID: 1820705 [TBL] [Abstract][Full Text] [Related]
13. Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice. Kamali AN; Marín-García P; Azcárate IG; Diez A; Puyet A; Bautista JM Immunobiology; 2012 Aug; 217(8):823-30. PubMed ID: 22658767 [TBL] [Abstract][Full Text] [Related]
14. The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes. Tachibana M; Ishino T; Tsuboi T; Torii M Vaccine; 2018 Nov; 36(49):7463-7471. PubMed ID: 30420038 [TBL] [Abstract][Full Text] [Related]
15. [Studies on the effective components in protective sera against Plasmodium yoelii infections in mice]. Cheng Q; Liu EX Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1988; 6(2):81-6. PubMed ID: 3180365 [No Abstract] [Full Text] [Related]
16. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants. Hunter RL; Kidd MR; Olsen MR; Patterson PS; Lal AA J Immunol; 1995 Feb; 154(4):1762-9. PubMed ID: 7836760 [TBL] [Abstract][Full Text] [Related]
17. Reactivity of autoantibodies against not only erythrocytes but also hepatocytes in sera of mice with malaria. Kanda Y; Kawamura T; Kobayashi T; Kawamura H; Watanabe H; Abo T Cell Immunol; 2014; 289(1-2):162-6. PubMed ID: 24838093 [TBL] [Abstract][Full Text] [Related]
18. Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo. Brahimi K; Badell E; Sauzet JP; BenMohamed L; Daubersies P; Guérin-Marchand C; Snounou G; Druilhe P Infect Immun; 2001 Jun; 69(6):3845-52. PubMed ID: 11349050 [TBL] [Abstract][Full Text] [Related]
19. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum. Xu L; Pei X; Berzins K; Chaudhuri A Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297 [TBL] [Abstract][Full Text] [Related]